Latest Headlines
-
Evosep Launches IQ/OQ Protocols For The Evosep Eno System At WCBP 2026
1/27/2026
WCBP - Evosep is proud to announce a major advancement in quality assurance for pharmaceutical and regulated laboratories with the introduction of Installation Qualification (IQ) and Operational Qualification (OQ) protocols for its Evosep Eno system.
-
Vortex Biotech Opens New State-Of-The-Art Laboratory At Manchester Science Park
1/27/2026
Vortex Biotech Holdings Limited has officially opened its new state‑of‑the‑art laboratory facilities at Manchester Science Park, marking a major milestone in the company’s growth and its mission to advance liquid biopsy technologies for precision oncology.
-
nRichDX And Hamilton Advance Automated Liquid Biopsy Sample Prep Solution With Unprecedented Capability
1/27/2026
Hamilton, a global leader in precision liquid handling and laboratory automation, and nRichDX, a leader in liquid biopsy sample preparation, today announced the continued momentum of their strategic collaboration to deliver automated, high-performance liquid biopsy sample preparation solutions.
-
Agilent Accelerates Digital Pathology With The Launch Of The Agilent S540MD Slide Scanner System
1/23/2026
Agilent Technologies Inc. today announced the launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, available for sale in key European markets.
-
Ozelle Brings AI-Powered, Scenario-Ready Diagnostics To WHX Labs Dubai 2026
1/23/2026
Ozelle, a global innovator in intelligent diagnostics, will showcase its next-generation solution at WHX Labs Dubai 2026 (Feb 10–13, Booth S1.D58).
-
BD Helps Scientists Advance Immunology And Cancer Research With AI-Powered Insights And Automation
1/23/2026
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of BD® Research Cloud 7.0, furthering the company's AI roadmap while strengthening its leadership in flow cytometry and life sciences research.
-
Pangea Laboratory And Gene Solutions Establish Strategic Collaboration To Advance Cancer Diagnostics In The United States
1/21/2026
Pangea Laboratory, a CLIA-certified, CAP-accredited leader in Next-Generation Sequencing (NGS) and molecular diagnostic validation and innovation, today announced a strategic collaboration with Gene Solutions, a global biotechnology company, to validate AI-driven liquid biopsy assays for use in cancer detection, characterization, and monitoring within CLIA/CAP laboratory settings in the U.S. market.
-
Zepto Life Technology Launches Plasma-Based FungiFlex® Mold Panel As CLIA Reference Laboratory Test
1/21/2026
Zepto Life Technology has announced the launch of the FungiFlex® Mold Panel, a plasma-based molecular diagnostic test now available through its CLIA-certified reference laboratory, expanding access to faster, noninvasive testing for patients at risk of invasive fungal infections (IFIs).
-
Sysmex America Expands CN-Series With CN-9000 To Help Labs Of All Sizes Optimize Workflow
1/21/2026
Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, today announced the newest addition to its CN-Series, the CN-9000 Automated Hemostasis Solution.
-
Cepheid Receives FDA Clearance For Xpert® GI Panel To Support Broad Detection Of Gastrointestinal Pathogens
1/20/2026
Cepheid announced today that it has received FDA clearance for Xpert GI Panel, a multiplex PCR test designed to provide fast and accurate detection of 11 clinically relevant gastrointestinal (GI) pathogens from a single patient sample.